
1. Mol Cancer. 2015 Aug 22;14:161. doi: 10.1186/s12943-015-0405-2.

Erratum: Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and
confers anoikis resistance by activating PI3-K signaling pathway independently of
Akt phosphorylation.

Toricelli M(1), Melo FH(1)(2), Peres GB(3), Silva DC(4), Jasiulionis MG(5).

Author information: 
(1)Pharmacology Department, Universidade Federal de São Paulo, São Paulo, Brazil.
(2)Microbiology, Immunology and Parasitology Department, Universidade Federal de 
São Paulo, São Paulo, Brazil.
(3)Biochemistry Department, Universidade Federal de São Paulo, São Paulo, Brazil.
(4)Ludwig Institute for Cancer Research, São Paulo, Brazil.
(5)Pharmacology Department, Universidade Federal de São Paulo, São Paulo, Brazil.
mjasiulionis@gmail.com.

Erratum for
    Mol Cancer. 2013;12:22.

DOI: 10.1186/s12943-015-0405-2 
PMCID: PMC4546186
PMID: 26297111 

